{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:03:03Z","timestamp":1791756183321,"version":"4.3.4"},"reference-count":95,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The high output heart failure is a clinical condition in which the systemic congestion is associated to a high output state, and it can be observed in a non-negligible percentage of hematological diseases, particularly in multiple myeloma, a condition in which the risk of adverse cardiovascular events may increase, with a worse prognosis for patients. For this reason, though an accurate literature search, we provided in this review a complete overview of different pathogenetic mechanisms responsible for high output heart failure in multiple myeloma. Indeed, this clinical finding is present in the 8% of multiple myeloma patients, and it may be caused by artero-venous shunts, enhanced angiogenesis, glutamminolysis, hyperammonemia and hemorheological alterations with increase in plasma viscosity. The high output heart failure in multiple myeloma is associated with significant morbidity and mortality, emphasizing the need for a multidisciplinary approach.<\/jats:p>","DOI":"10.3390\/cancers14030610","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T03:33:32Z","timestamp":1643168012000},"page":"610","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations"],"prefix":"10.3390","volume":"14","author":[{"given":"Melania","family":"Carlisi","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatrice","family":"Mancuso","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Lo Presti","sequence":"additional","affiliation":[{"name":"Department of Psychology, Educational Science and Human Movement, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Siragusa","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Caimi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11936-001-0070-1","article-title":"High output cardiac failure","volume":"3","author":"Anand","year":"2001","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/qjmed\/hcn147","article-title":"High output heart failure","volume":"102","author":"Mehta","year":"2009","journal-title":"QJM"},{"key":"ref_3","unstructured":"Singh, S., and Sharma, S. (2021). High-Output Cardiac Failure. Current Treatment Options in Cardiovascular Medicine, StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2016.05.043","article-title":"High-Output Heart Failure: A 15-Year Experience","volume":"68","author":"Reddy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41408-019-0183-y","article-title":"Management of cardiovascular risk in patients with multiple myeloma","volume":"9","author":"Plummer","year":"2019","journal-title":"Blood Cancer J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1080\/10428194.2017.1393674","article-title":"Cardio-oncology in multiple myeloma: Is it time for a specific focus?","volume":"59","author":"Mancuso","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198812223192506","article-title":"High-output cardiac failure in patients with multiple myeloma","volume":"319","author":"McBride","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/clc.4960171211","article-title":"High cardiac output state in patients with multiple myeloma: Case report and review of the literature","volume":"17","author":"Kosisnski","year":"1994","journal-title":"Clin. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0002-9343(90)90092-R","article-title":"Prevalence and clinical characteristics of a high cardiac output state in patients with multiple myeloma","volume":"89","author":"McBride","year":"1990","journal-title":"Am. J. Med."},{"key":"ref_10","first-page":"214","article-title":"High cardiac output in myeloma patients. Its prevalence and clinical characteristics. The Castile-Leon Cooperative Group for the Study of Monoclonal Gammapathies","volume":"108","author":"Lopez","year":"1997","journal-title":"Med. Clin."},{"key":"ref_11","first-page":"1","article-title":"Arteriovenous shunting in patients with multiple myeloma and high-output failure","volume":"39","author":"Inanir","year":"1998","journal-title":"J. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM198905253202116","article-title":"High-Output Cardiac Failure in Multiple Myeloma","volume":"320","author":"Leporrier","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(69)91354-3","article-title":"The spleen as an arteriovenous shunt","volume":"1","author":"Garnett","year":"1969","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e22299","DOI":"10.1097\/MD.0000000000022299","article-title":"Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma. A case report and literature review","volume":"99","author":"Mendes","year":"2020","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/kjm2.12186","article-title":"Case report of coexistence of myeloproliferative neoplasms and multiple myeloma","volume":"36","author":"Gau","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_16","first-page":"rjz021","article-title":"Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma","volume":"3","author":"Buzalewski","year":"2019","journal-title":"J. Surg. Case Rep."},{"key":"ref_17","first-page":"679","article-title":"High-output cardiac failure as a presenting symptom of plasma cell leukemia","volume":"21","author":"Tamir","year":"1985","journal-title":"Isr. J. Med. Sci."},{"key":"ref_18","first-page":"504612","article-title":"High-output cardiac failure revealing primary plasma cell leukemia","volume":"2013","author":"Chaoui","year":"2013","journal-title":"Case Rep. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10245330400018524","article-title":"Angiogenic switch in multiple myeloma","volume":"9","author":"Giuliani","year":"2004","journal-title":"Hematology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","article-title":"Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma","volume":"25","author":"Ribatti","year":"2006","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1532\/IJH97.06226","article-title":"Analysis of serum angiogenic factors in young multiple myeloma patient with high-output cardiac failure","volume":"86","author":"Sasaki","year":"2007","journal-title":"Int. J. Hematol."},{"key":"ref_22","first-page":"76","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"1","author":"Ria","year":"2011","journal-title":"Am. J. Blood Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12307-011-0072-9","article-title":"Angiogenesis and multiple myeloma","volume":"4","author":"Giuliani","year":"2011","journal-title":"Cancer Microenviron."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10456-013-9369-2","article-title":"Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma","volume":"16","author":"Binetti","year":"2013","journal-title":"Angiogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000353312","article-title":"Angiogenesis in multiple myeloma","volume":"99","author":"Vacca","year":"2014","journal-title":"Chem. Immunol. Allergy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-319-40320-5_5","article-title":"Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch","volume":"169","author":"Ribatti","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ribatti, D., and Vacca, A. (2018). New insights in anti-angiogenesis in multiple myeloma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072031"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.leu.2404402","article-title":"The history of the angiogenic switch concept","volume":"21","author":"Ribatti","year":"2007","journal-title":"Leukemia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3343\/alm.2015.35.6.563","article-title":"Adverse prognostic impact of bone marrow microvessel density in multiple myeloma","volume":"35","author":"Lee","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ribatti, D., Tamma, R., and Vacca, A. (2019). Mast cells and angiogenesis in human plasma cell malignancies. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030481"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.leu.2404067","article-title":"Bone marrow angiogenesis in multiple myeloma","volume":"20","author":"Vacca","year":"2005","journal-title":"Leukemia"},{"key":"ref_32","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ejca.2006.02.017","article-title":"Angiogenesis in multiple myeloma","volume":"42","author":"Akob","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: Evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/leu.2009.55","article-title":"The role of monocytes-macrophages in vasculogenesis in multiple myeloma","volume":"23","author":"Ribatti","year":"2009","journal-title":"Leukemia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12185-011-0963-z","article-title":"Biological aspects of angiogenesis in multiple myeloma","volume":"94","author":"Otjacques","year":"2011","journal-title":"Int. J. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.18632\/oncotarget.1736","article-title":"Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma","volume":"5","author":"Borsi","year":"2014","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.trsl.2014.12.001","article-title":"Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma","volume":"165","author":"Borsi","year":"2015","journal-title":"Transl. Res."},{"key":"ref_39","first-page":"706","article-title":"Hypoxia inducible factor-1 alpha and multiple myeloma","volume":"4","author":"Bhaskar","year":"2016","journal-title":"Int. J. Adv. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/sci.2016.06.07","article-title":"Endothelial progenitor cells in hematological malignancies","volume":"3","author":"Testa","year":"2016","journal-title":"Stem Cell Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1182\/blood.V99.12.4525","article-title":"Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mvr.2008.08.003","article-title":"The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions","volume":"77","author":"Lu","year":"2009","journal-title":"Microvasc. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood-2005-10-4184","article-title":"Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: Therapeutic implications","volume":"108","author":"Chang","year":"2006","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bloedjes, T.A., de Wilde, G., and Guikema, J.E.J. (2021). Metabolic effects of recurrent genetic aberrations in multiple myeloma. Cancers, 13.","DOI":"10.3390\/cancers13030396"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1242\/jcs.21.3.609","article-title":"Amino acid metabolism of myeloma in culture","volume":"21","author":"Roberts","year":"1976","journal-title":"J. Cell Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/bit.260440916","article-title":"Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells","volume":"44","author":"Mercille","year":"1994","journal-title":"Biotechnol. Bioeng."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1158\/1078-0432.CCR-12-2917","article-title":"Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission","volume":"19","author":"Lecumberri","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"C-Myc suppression of MiR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated C-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2169\/internalmedicine.31.339","article-title":"Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia","volume":"31","author":"Matsuzaki","year":"1992","journal-title":"Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2796.1993.tb00987.x","article-title":"Hyperammonaemic encephalopathy as the presenting feature of IgD multiple myeloma","volume":"233","author":"Caminal","year":"1993","journal-title":"J. Intern. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0925-5710(95)00359-Z","article-title":"Serum amino acid disturbance in multiple myeloma with hyperammonemia","volume":"61","author":"Matsuzaki","year":"1995","journal-title":"Int. J. Hematol."},{"key":"ref_54","first-page":"918","article-title":"A patient with ammonia-producing multiple myeloma showing hyperammonemic encephalopathy","volume":"10","author":"Takimoto","year":"1996","journal-title":"Leukemia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1023\/A:1008236018377","article-title":"Clinical manifestation of severe hyperammonemia in patients with multiple myeloma","volume":"8","author":"Martinelli","year":"1997","journal-title":"Ann. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<77::AID-AJH14>3.0.CO;2-6","article-title":"Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure","volume":"57","author":"Kuribayashi","year":"1998","journal-title":"Am. J. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<264::AID-AJH23>3.0.CO;2-9","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"57","author":"Keller","year":"1998","journal-title":"Am. J. Hematol."},{"key":"ref_58","first-page":"956","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"83","author":"Marco","year":"1998","journal-title":"Haematologica"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.leu.2401077","article-title":"In vitro excess ammonia production in human myeloma cell lines","volume":"12","author":"Otsuki","year":"1998","journal-title":"Leukemia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJM200205233462119","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"346","author":"Kwan","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjmed.2003.06.010","article-title":"Hyperammonemia: Elevated ammonia levels in multiple myeloma","volume":"116","author":"Holahan","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0019-5359.13815","article-title":"Hyperammonemia: An unusual presenting feature of multiple myeloma","volume":"59","author":"Shah","year":"2005","journal-title":"Indian J. Med. Sci."},{"key":"ref_63","first-page":"557","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"9","author":"Furer","year":"2007","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ajh.20808","article-title":"Hyperammonemia and encephalopathy in patients with multiple myeloma","volume":"82","author":"Talamo","year":"2007","journal-title":"Am. J. Hematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3816\/CLM.2008.n.054","article-title":"Multiple myeloma and hyperammonemic encephalopathy: Review of 27 cases","volume":"8","author":"Palom","year":"2008","journal-title":"Clin. Lymphoma Myeloma"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/10428190902741489","article-title":"Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells","volume":"50","author":"Ikewaki","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1532-5415.2010.02994.x","article-title":"Multiple myeloma presenting as hyperammonemic encephalopathy","volume":"58","author":"Alexandra","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.leukres.2013.07.014","article-title":"Multiple myeloma-induced hyperammonemic encephalopathy: An entity associated with high in-patients mortality","volume":"37","author":"Pham","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e24157","DOI":"10.1097\/MD.0000000000024157","article-title":"Analysis of clinical prognosis in patients with non-hepatic hyperammonemia","volume":"100","author":"Li","year":"2021","journal-title":"Medicine"},{"key":"ref_70","unstructured":"Murray, R.K., Granner, D.K., Mayes, P.A., and Rodwell, V.W. (2000). Harper\u2019s Biochemistry, McGraw-Hill."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Krebs, H.A., and Veech, R.L. (1970). Regulation of the redox state of pyridine nucleotids in rat liver. Pyridine Nucleotide Dependent Dehydrogenases, Springer.","DOI":"10.1007\/978-3-642-49974-6_35"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1874-6047(08)60155-9","article-title":"Glutamine Synthetase of Mammals","volume":"Volume 10","author":"Boyer","year":"1974","journal-title":"The Enzymes"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0968-0004(97)01147-X","article-title":"Biosynthesis and action of nitric oxide in mammalian cells","volume":"22","author":"Mayer","year":"1998","journal-title":"Trends Biochem. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/joim.12461","article-title":"Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels","volume":"279","author":"Kovamees","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/joim.12785","article-title":"Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose-lowering therapy","volume":"284","author":"Mahdi","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/CH-131691","article-title":"Hyperviscosity in plasma cell dyscrasias","volume":"55","author":"Kwaan","year":"2013","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.clinbiochem.2014.11.006","article-title":"Whole blood viscosity in plasma cell dyscrasia","volume":"48","author":"Uggla","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.revmed.2015.02.005","article-title":"Hyperviscosity syndrome","volume":"36","author":"Dumas","year":"2015","journal-title":"Rev. Med. Interne."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/CH-170267","article-title":"Erythrocyte deformability and hemorheological profile in multiple myeloma","volume":"68","author":"Caimi","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/CH-170289","article-title":"Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS)","volume":"68","author":"Caimi","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"104171","DOI":"10.1016\/j.mvr.2021.104171","article-title":"Reflections on the unexpected laboratory finding of hemorheological alterations observed in some hematological disorders","volume":"136","author":"Caimi","year":"2021","journal-title":"Microvasc. Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Carlisi, M., Mancuso, S., Lo Presti, R., Siragusa, S., and Caimi, G. (2021). Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey. Clin. Hemorheol. Microcirc.","DOI":"10.3233\/CH-211198"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.fluid.37.042604.133933","article-title":"Microcirculation and hemorheology","volume":"37","author":"Popel","year":"2005","journal-title":"Annu. Rev. Fluid Mech."},{"key":"ref_84","unstructured":"Baskurt, O.K., Hardeman, M.R., Rampling, M.W., and Meiselman, H.J. (2007). Endothelium and hemorheology. Handbook of Hemorheology and Hemodynamics, IOS Press."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/CH-2011-1498","article-title":"Endothelium and hyperviscosity","volume":"49","author":"Forconi","year":"2011","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/CH-2012-1571","article-title":"Endothelium and hemorheology","volume":"53","author":"Forconi","year":"2013","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"H1730","DOI":"10.1152\/ajpheart.00998.2004","article-title":"Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion","volume":"288","author":"Tsai","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H581","DOI":"10.1152\/ajpheart.01279.2005","article-title":"Blood viscosity maintains microvascular conditions during normovolemic anemia independent of blood oxygen-carrying capacity","volume":"291","author":"Cabrales","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pcad.2006.11.001","article-title":"Wall shear stress: Theoretical considerations and methods of measurement","volume":"49","author":"Katritsis","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/micc.12141","article-title":"Non-Newtonian flow of blood in arterioles: Consequences of wall shear stress measurements","volume":"21","author":"Sriram","year":"2014","journal-title":"Microcirculation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/ATVBAHA.114.303422","article-title":"Shear stress-initiated signaling and its regulation of endothelial function","volume":"34","author":"Zhou","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Uzarski, J.S., Scott, E.W., and McFetridge, P.S. (2013). Adaptation of endothelial cells to physiologically-modeled, variable shear stress. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057004"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1161\/ATVBAHA.114.303428","article-title":"Novel mechanisms of endothelial mechanotransduction","volume":"34","author":"Abe","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/physrev.00042.2007","article-title":"eNOS activation by physical forces: From short-term regulation of contraction to chronic remodeling of cardiovascular tissues","volume":"89","author":"Balligand","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bpj.2016.05.034","article-title":"Shear-induced nitric oxide production by endothelial cells","volume":"111","author":"Sriram","year":"2016","journal-title":"Biophys. J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/3\/610\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:07:51Z","timestamp":1760134071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/3\/610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":95,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cancers14030610"],"URL":"https:\/\/doi.org\/10.3390\/cancers14030610","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}